Mendelian randomization of circulating proteome identifies actionable targets in heart failure
Abstract Background Heart failure (HF) is a prevalent cause of mortality and morbidity. The molecular drivers of HF are still largely unknown. Results We aimed to identify circulating proteins causally associated with HF by leveraging genome-wide genetic association data for HF including 47,309 case...
Main Authors: | Louis-Hippolyte Minvielle Moncla, Samuel Mathieu, Mame Sokhna Sylla, Yohan Bossé, Sébastien Thériault, Benoit J. Arsenault, Patrick Mathieu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | BMC Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12864-022-08811-2 |
Similar Items
-
Enhancer promoter interactome and Mendelian randomization identify network of druggable vascular genes in coronary artery disease
by: Arnaud Chignon, et al.
Published: (2022-03-01) -
Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analysesResearch in context
by: Naiqi Zhang, et al.
Published: (2023-12-01) -
Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease
by: Zihui Wang, et al.
Published: (2024-04-01) -
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro
by: Qing-Qing Duan, et al.
Published: (2024-03-01) -
Connectome and regulatory hubs of CAGE highly active enhancers
by: Mewen Briend, et al.
Published: (2023-04-01)